Clofazimine inhibits the growth of Babesia and Theileria parasites in vitro and in vivo

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 5, 2016, Pages 2739-2746

  Tuvshintulga, Bumduuren ^a,c   AbouLaila, Mahmoud ^a,b   Davaasuren, Batdorj ^a,c   Ishiyama, Aki ^d   Sivakumar, Thillaiampalam ^a   Yokoyama, Naoaki ^a   Iwatsuki, Masato ^d   Otoguro, Kazuhiko ^d   Omura, Satoshi ^d   Igarashi, Ikuo ^a  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^b University of Sadat City   (Egypt)

^c Institute of Veterinary Medicine   (Mongolia)

^d KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; DIMINAZENE ACETURATE; PROTOZOAL DNA; ANTIMALARIAL AGENT;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMALARIAL ACTIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; BABESIA BIGEMINA; BABESIA BOVIS; BABESIA CABALLI; BABESIA MICROTI; BLOOD ANALYSIS; BLOOD SMEAR; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GROWTH INHIBITION; IC50; IN VITRO STUDY; IN VIVO STUDY; LEPROSY; MICROBIAL GROWTH; MOUSE; NONHUMAN; PARASITEMIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THEILERIA EQUI; ANIMAL; BABESIA; BAGG ALBINO MOUSE; DRUG EFFECTS; ERYTHROCYTE; PATHOGENICITY; PLASMODIUM FALCIPARUM; THEILERIA;

ANIMALS; ANTIMALARIALS; BABESIA; CLOFAZIMINE; ERYTHROCYTES; FEMALE; MICE; MICE, INBRED BALB C; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; THEILERIA;

EID: 84964917825     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01614-15     Document Type: Article

References (31)

1. Bock R, Jackson L, de Vos A, Jorgensen W. 2004. Babesiosis of cattle. Parasitology 129:S247-S269. http://dx.doi.org/10.1017/S0031182004005190.
2. Homer MJ, Aguilar-Delfin I, Telford SR, Krause PJ, Persing DH. 2000. Babesiosis. Clin Microbiol Rev 13:451-469. http://dx.doi.org/10.1128/CMR.13.3.451-469.2000.
3. Bishop R, Musoke A, Morzaria S, Gardner M, Nene V. 2004. Theileria: intracellular protozoan parasites of wild and domestic ruminants transmitted by ixodid ticks. Parasitology 129:S271-283. http://dx.doi.org/10.1017/S0031182003004748.
4. Wise LN, Kappmeyer LS, Mealey RH, Knowles DP. 2013. Review of equine piroplasmosis. J Vet Intern Med 27:1334-1346. http://dx.doi.org/10.1111/jvim.12168.
5. Mosqueda J, Olvera-Ramirez A, Aguilar-Tipacamu G, Canto GJ. 2012. Current advances in detection and treatment of babesiosis. Curr Med Chem 19:1504-1518. http://dx.doi.org/10.2174/092986712799828355.
6. Vial HJ, Gorenflot A. 2006. Chemotherapy against babesiosis. Vet Parasitol 138:147-160. http://dx.doi.org/10.1016/j.vetpar.2006.01.048.
7. Van Rensburg CE, Van Staden AM, Anderson R. 1993. The riminophenazine agents clofazimine and B669 inhibit the proliferation of cancer cell lines in vitro by phospholipase A2 mediated oxidative and nonoxidative mechanisms. Cancer Res 53:318-323.
8. Barry VC, Conalty V. 1965. The antimycobacterial activity of B663. Lepr Rev 36:3-7.
9. Reddy VM, Nadadhur G, Daneluzzi D, O'Sullivan JF, Gangadharam PJ. 1996. Antituberculosis activities of clofazimine and its new analogs B4154 and B4157. Antimicrob Agents Chemother 40:633-636.
10. Bygum A, Toft-Petersen M. 2008. Melkersson-Rosenthal syndrome treated with clofazimine. Ugeskr Laeger 170:159.
11. Evans AT, Croft SL, Peters W, Neal RA. 1989. Antileishmanial effects of clofazimine and other antimycobacterial agents. Ann Trop Med Parasitol 83:447-454.
12. Mahmoudi N, de Julián-Ortiz JV, Ciceron L, Gálvez J, Mazier D, Danis M, Derouin F, Garciá-Domenech R. 2006. Identification of new antimalarial drugs by linear discriminant analysis and topological virtual screening. J Antimicrob Chemother 57:489-497. http://dx.doi.org/10.1093/jac/dki470.
13. Otoguro K, Ishiyama A, Iwatsuki M, Namatame M, Nishihara-Tukashima A, Nakashima T, Shibahara S, Kondo S, Yamada H, Ōmura S. 2010. In vitro and in vivo anti-Trypanosoma brucei activities of phenazinomycin and related compounds. J Antibiot 63:579-581. http://dx.doi.org/10.1038/ja.2010.72.
14. AbouLaila M, Munkhjargal T, Sivakumar T, Ueno A, Nakano Y, Yokoyama M, Yoshinari T, Nagano D, Katayama K, El-Bahy N, Yokoyama N, Igarashi I. 2012. Apicoplast-targeting antibacterials inhibit the growth of Babesia parasites. Antimicrob Agents Chemother 56:3196-3206. http://dx.doi.org/10.1128/AAC.05488-11.
15. Igarashi I, Njonge FK, Kaneko Y, Nakamura Y. 1998. Babesia bigemina: in vitro and in vivo effects of curdlan sulfate on growth of parasites. Exp Parasitol 90:290-293. http://dx.doi.org/10.1006/expr.1998.4331.
16. AbouLaila M, Davaasuren B, Salama A, Ichikawa M, Terkawi MA, Munkhjargal T, Yokoyama N, Igarashi I. 2014. Evaluation of the inhibitory effects of miltefosine on the growth of Babesia and Theileria parasites. Vet Parasitol 204:104-110. http://dx.doi.org/10.1016/j.vetpar.2014.05.023.
17. Otoguro K, Kohana A, Manabe C, Ishiyama A, Ui H, Shiomi K, Yamada H, Ōmura S. 2001. Potent antimalarial activities of polyether antibiotic, X-206. J Antibiot 54:658-663. http://dx.doi.org/10.7164/antibiotics.54.658.
18. Makler MT, Ries JM, Williams JA, Bancroft JE, Piper RC, Gibbins BL, Hinrichs DJ. 1993. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am J Trop Med Hyg 48:739-741.
19. Vivas L, Easton A, Kendrick H, Cameron A, Lavandera JL, Barros D, de las Heras FG, Brady RL, Croft SL. 2005. Plasmodium falciparum: stage specific effects of a selective inhibitor of lactate dehydrogenase. Exp Parasitol 111:105-114. http://dx.doi.org/10.1016/j.exppara.2005.06.007.
20. Persing DH, Mathiesen D, Marshall WF, Telford SR, Spielman A, Thomford JW, Conrad PA. 1992. Detection of Babesia microti by polymerase chain reaction. J Clin Microbiol 30:2097-2103.
21. Makgatho ME, Anderson R, O'Sullivan JF, Egan TJ, Freese JA, Cornelius N, van Rensburg CEJ. 2000. Tetramethylpiperidine-substituted phenazines as novel anti-plasmodial agents. Drug Dev Res 50:195-202.
22. Datta G, Bera T. 2000. The effects of clofazimine, niclosamide and amphotericin B, on electron transport of Leishmania donovani promastigotes. Indian J Med Res 112:15-20.
23. Mehta RT. 1996. Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex infection. Antimicrob Agents Chemother 40:1893-1902.
24. Endoh M, Kunishita T, Tabira T. 1999. No effect of anti-leprosy drugs in the prevention of Alzheimer's disease and beta-amyloid neurotoxicity. J Neurol Sci 165:28-30.
25. Yawalkar SJ, Vischer W. 1979. Lamprene (clofazimine) in leprosy. Basic information. Lepr Rev 50:135-144.
26. Sasaki M, Fujii Y, Iwamoto M, Ikadai H. 2013. Effect of sex steroids on Babesia microti infection in mice. Am J Trop Med Hyg 88:367-375. http://dx.doi.org/10.4269/ajtmh.2012.12-0338.
27. Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, Furin JJ, Fitzmaurice GM, Alcantara Viru FA, Appleton SC, Bayona JN, Bonilla CA, Chalco K, Choi S, Franke MF, Fraser HS, Guerra D, Hurtado RM, Jazayeri D, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Muñoz M, Palacios E, Sanchez E, Sloutsky A, Becerra MC. 2008. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med 359: 563-574. http://dx.doi.org/10.1056/NEJMoa0800106.
28. AbouLaila M, Yokoyama N, Igarashi I. 2010. Inhibitory effects of (-)-epigallocatechin-3-gallate from green tea on the growth of Babesia parasites. Parasitology 137:785-791. http://dx.doi.org/10.1017/S0031182009991594.
29. Salama AA, AbouLaila M, Terkawi MA, Mousa A, El-Sify A, Allaam M, Zaghawa A, Yokoyama N, Igarashi I. 2014. Inhibitory effect of allicin on the growth of Babesia and Theileria equi parasites. Parasitol Res 113:275-283. http://dx.doi.org/10.1007/s00436-013-3654-2.
30. Andrews KT, Fisher G, Skinner-Adams TS. 2014. Drug repurposing and human parasitic protozoan diseases. Int J Parasitol Drugs Drug Resist 4:95-111. http://dx.doi.org/10.1016/j.ijpddr.2014.02.002.
31. Vannier E, Krause PJ. 2012. Human babesiosis. N Engl J Med 366:2397-2407. http://dx.doi.org/10.1056/NEJMra1202018.